Back to Journals » OncoTargets and Therapy » Volume 14

Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC

Total article views   HTML views PDF downloads Totals
5,992 Dovepress* 5,245+ 595 5,840
PubMed Central* 747 139 886
Totals 5,992 734 6,726
*Since 25 May 2021
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 1 3 5

View citations on PubMed Central and Google Scholar